Liensinine inhibits progression of intrahepatic cholangiocarcinoma by regulating TGF‐β1 /P‐smad3 signaling through HIF‐1a.

Autor: Zhu, Xuewen, Bao, Wenming, Xie, Xiaozai, Chen, Bo, Li, Rizhao, Zhao, Jungang, Wu, Lijun, Yu, Zhengping, Li, Shi, Zhu, Qiandong, Chen, Gang, Li, Jiacheng
Zdroj: Molecular Carcinogenesis; Apr2024, Vol. 63 Issue 4, p772-784, 13p
Databáze: Complementary Index
Externí odkaz: